Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type.

Breen N, Skinner CS, Zheng Y, Inrig S, Corley DA, Beaber EF, Garcia M, Chubak J, Doubeni C, Quinn VP, Haas JS, Li CI, Wernli KJ, Klabunde CN; PROSPR consortium.

Am J Prev Med. 2019 May;56(5):e143-e152. doi: 10.1016/j.amepre.2019.01.005.

PMID:
31003603
2.

Lung Cancer Screening Inconsistent With U.S. Preventive Services Task Force Recommendations.

Richards TB, Doria-Rose VP, Soman A, Klabunde CN, Caraballo RS, Gray SC, Houston KA, White MC.

Am J Prev Med. 2019 Jan;56(1):66-73. doi: 10.1016/j.amepre.2018.07.030. Epub 2018 Nov 19.

PMID:
30467092
3.

Sources of Funding for Research in Evidence Reviews That Inform Recommendations of the US Preventive Services Task Force.

Villani J, Ngo-Metzger Q, Vincent IS, Klabunde CN.

JAMA. 2018 May 22;319(20):2132-2133. doi: 10.1001/jama.2018.5404. No abstract available.

4.

Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverage.

de Moor JS, Cohen RA, Shapiro JA, Nadel MR, Sabatino SA, Robin Yabroff K, Fedewa S, Lee R, Paul Doria-Rose V, Altice C, Klabunde CN.

Prev Med. 2018 Jul;112:199-206. doi: 10.1016/j.ypmed.2018.05.001. Epub 2018 May 3.

5.

Medical Oncologists' Experiences in Using Genomic Testing for Lung and Colorectal Cancer Care.

Gray SW, Kim B, Sholl L, Cronin A, Parikh AR, Klabunde CN, Kahn KL, Haggstrom DA, Keating NL.

J Oncol Pract. 2017 Mar;13(3):e185-e196. doi: 10.1200/JOP.2016.016659. Epub 2017 Jan 17.

6.

Oncologists' perspectives on post-cancer treatment communication and care coordination with primary care physicians.

Klabunde CN, Haggstrom D, Kahn KL, Gray SW, Kim B, Liu B, Eisenstein J, Keating NL.

Eur J Cancer Care (Engl). 2017 Jul;26(4). doi: 10.1111/ecc.12628. Epub 2017 Jan 10.

7.

Primary Care Providers' Beliefs and Recommendations and Use of Screening Mammography by their Patients.

Haas JS, Barlow WE, Schapira MM, MacLean CD, Klabunde CN, Sprague BL, Beaber EF, Chen JS, Bitton A, Onega T, Harris K, Tosteson ANA; PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) consortium.

J Gen Intern Med. 2017 Apr;32(4):449-457. doi: 10.1007/s11606-016-3973-y. Epub 2017 Jan 9.

8.

Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly.

Klabunde CN, Zheng Y, Quinn VP, Beaber EF, Rutter CM, Halm EA, Chubak J, Doubeni CA, Haas JS, Kamineni A, Schapira MM, Vacek PM, Garcia MP, Corley DA; PROSPR consortium.

Am J Prev Med. 2016 Sep;51(3):e67-75. doi: 10.1016/j.amepre.2016.04.018. Epub 2016 Jun 22.

9.

Inadequate Systems to Support Breast and Cervical Cancer Screening in Primary Care Practice.

Schapira MM, Sprague BL, Klabunde CN, Tosteson AN, Bitton A, Chen JS, Beaber EF, Onega T, MacLean CD, Harris K, Howe K, Pearson L, Feldman S, Brawarsky P, Haas JS; PROSPR consortium.

J Gen Intern Med. 2016 Oct;31(10):1148-55. doi: 10.1007/s11606-016-3726-y. Epub 2016 Jun 1.

10.

Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity.

McCarthy AM, Kim JJ, Beaber EF, Zheng Y, Burnett-Hartman A, Chubak J, Ghai NR, McLerran D, Breen N, Conant EF, Geller BM, Green BB, Klabunde CN, Inrig S, Skinner CS, Quinn VP, Haas JS, Schnall M, Rutter CM, Barlow WE, Corley DA, Armstrong K, Doubeni CA; PROSPR consortium.

Am J Prev Med. 2016 Oct;51(4):507-12. doi: 10.1016/j.amepre.2016.03.017. Epub 2016 Apr 28.

11.

Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer.

Parikh AR, Keating NL, Liu PH, Gray SW, Klabunde CN, Kahn KL, Haggstrom DA, Syngal S, Kim B.

J Oncol Pract. 2016 Mar;12(3):e308-19, 259-60. doi: 10.1200/JOP.2015.007062.

12.

Take the money and run? Redemption of a gift card incentive in a clinician survey.

Chen JS, Sprague BL, Klabunde CN, Tosteson AN, Bitton A, Onega T, MacLean CD, Harris K, Schapira MM, Haas JS; PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) Consortium.

BMC Med Res Methodol. 2016 Feb 24;16:25. doi: 10.1186/s12874-016-0126-2.

13.

Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems.

Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, Singal AG, Klabunde CN, Doubeni CA, Kamineni A, Levin TR, Schottinger JE, Green BB, Quinn VP, Rutter CM; PROSPR consortium.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):344-50. doi: 10.1158/1055-9965.EPI-15-0470.

14.

Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study.

Jensen CD, Corley DA, Quinn VP, Doubeni CA, Zauber AG, Lee JK, Zhao WK, Marks AR, Schottinger JE, Ghai NR, Lee AT, Contreras R, Klabunde CN, Quesenberry CP, Levin TR, Mysliwiec PA.

Ann Intern Med. 2016 Apr 5;164(7):456-63. doi: 10.7326/M15-0983. Epub 2016 Jan 26.

15.

Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines.

Haas JS, Sprague BL, Klabunde CN, Tosteson AN, Chen JS, Bitton A, Beaber EF, Onega T, Kim JJ, MacLean CD, Harris K, Yamartino P, Howe K, Pearson L, Feldman S, Brawarsky P, Schapira MM; PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) Consortium.

J Gen Intern Med. 2016 Jan;31(1):52-9. doi: 10.1007/s11606-015-3449-5.

16.

Cancer screening test use - United States, 2013.

Sabatino SA, White MC, Thompson TD, Klabunde CN; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):464-8.

17.

Colorectal Cancer Screening in US Seniors Ages 76-84 Years.

Klabunde CN, Shapiro JA, Kobrin S, Nadel MR, Zapka JM.

J Community Health. 2015 Aug;40(4):769-79. doi: 10.1007/s10900-015-9998-z.

18.

Opportunities and challenges for the use of large-scale surveys in public health research: a comparison of the assessment of cancer screening behaviors.

Hamilton JG, Breen N, Klabunde CN, Moser RP, Leyva B, Breslau ES, Kobrin SC.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):3-14. doi: 10.1158/1055-9965.EPI-14-0568. Epub 2014 Oct 9. Review.

19.

Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.

Kehl KL, Arora NK, Schrag D, Ayanian JZ, Clauser SB, Klabunde CN, Kahn KL, Fletcher RH, Keating NL.

J Natl Cancer Inst. 2014 Sep 13;106(10). pii: dju216. doi: 10.1093/jnci/dju216. Print 2014 Oct.

20.

Physician-reported barriers to referring cancer patients to specialists: prevalence, factors, and association with career satisfaction.

Kwon DH, Tisnado DM, Keating NL, Klabunde CN, Adams JL, Rastegar A, Hornbrook MC, Kahn KL.

Cancer. 2015 Jan 1;121(1):113-22. doi: 10.1002/cncr.29019. Epub 2014 Sep 5.

21.

The appropriateness of more intensive colonoscopy screening than recommended in Medicare beneficiaries: a modeling study.

van Hees F, Zauber AG, Klabunde CN, Goede SL, Lansdorp-Vogelaar I, van Ballegooijen M.

JAMA Intern Med. 2014 Oct;174(10):1568-76. doi: 10.1001/jamainternmed.2014.3889.

22.

Influence of provider discussion and specific recommendation on colorectal cancer screening uptake among U.S. adults.

Laiyemo AO, Adebogun AO, Doubeni CA, Ricks-Santi L, McDonald-Pinkett S, Young PE, Cash BD, Klabunde CN.

Prev Med. 2014 Oct;67:1-5. doi: 10.1016/j.ypmed.2014.06.022. Epub 2014 Jun 23.

23.

Challenges in meeting Healthy People 2020 objectives for cancer-related preventive services, National Health Interview Survey, 2008 and 2010.

Brown ML, Klabunde CN, Cronin KA, White MC, Richardson LC, McNeel TS.

Prev Chronic Dis. 2014 Feb 27;11:E29. doi: 10.5888/pcd11.130174.

24.

Physicians' preferences for hospice if they were terminally ill and the timing of hospice discussions with their patients.

Chinn GM, Liu PH, Klabunde CN, Kahn KL, Keating NL.

JAMA Intern Med. 2014 Mar;174(3):466-8. doi: 10.1001/jamainternmed.2013.12825. No abstract available. Erratum in: JAMA Intern Med. 2014 Mar;174(3):484.

25.

Reply to U. Tirelli et al.

Virgo KS, Lerro CC, Klabunde CN, Earle C, Ganz PA.

J Clin Oncol. 2014 Jan 20;32(3):258. doi: 10.1200/JCO.2013.52.7622. Epub 2013 Dec 2. No abstract available.

PMID:
24297957
26.

Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies.

Cho H, Klabunde CN, Yabroff KR, Wang Z, Meekins A, Lansdorp-Vogelaar I, Mariotto AB.

Ann Intern Med. 2013 Nov 19;159(10):667-76. doi: 10.7326/0003-4819-159-10-201311190-00005.

PMID:
24247672
27.

Organization of primary care practice for providing energy balance care.

Klabunde CN, Clauser SB, Liu B, Pronk NP, Ballard-Barbash R, Huang TT, Smith AW.

Am J Health Promot. 2014 Jan-Feb;28(3):e67-80. doi: 10.4278/ajhp.121219-QUAN-626. Epub 2013 Nov 7.

PMID:
24200333
28.

Life tables adjusted for comorbidity more accurately estimate noncancer survival for recently diagnosed cancer patients.

Mariotto AB, Wang Z, Klabunde CN, Cho H, Das B, Feuer EJ.

J Clin Epidemiol. 2013 Dec;66(12):1376-85. doi: 10.1016/j.jclinepi.2013.07.002. Epub 2013 Sep 10.

29.

Facilitators and barriers to survey participation by physicians: a call to action for researchers.

Klabunde CN, Willis GB, Casalino LP.

Eval Health Prof. 2013 Sep;36(3):279-95. doi: 10.1177/0163278713496426.

PMID:
23975758
30.

Physician roles in the cancer-related follow-up care of cancer survivors.

Klabunde CN, Han PK, Earle CC, Smith T, Ayanian JZ, Lee R, Ambs A, Rowland JH, Potosky AL.

Fam Med. 2013 Jul-Aug;45(7):463-74.

31.

National evidence on the use of shared decision making in prostate-specific antigen screening.

Han PK, Kobrin S, Breen N, Joseph DA, Li J, Frosch DL, Klabunde CN.

Ann Fam Med. 2013 Jul-Aug;11(4):306-14. doi: 10.1370/afm.1539.

32.

Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.

Cho H, Mariotto AB, Mann BS, Klabunde CN, Feuer EJ.

Am J Epidemiol. 2013 Aug 1;178(3):339-49. doi: 10.1093/aje/kws580. Epub 2013 Jul 3.

33.

Enrollment of patients with lung and colorectal cancers onto clinical trials.

Fouad MN, Lee JY, Catalano PJ, Vogt TM, Zafar SY, West DW, Simon C, Klabunde CN, Kahn KL, Weeks JC, Kiefe CI.

J Oncol Pract. 2013 Mar;9(2):e40-7. doi: 10.1200/JOP.2012.000598.

34.

Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States.

Virgo KS, Lerro CC, Klabunde CN, Earle C, Ganz PA.

J Clin Oncol. 2013 Jun 20;31(18):2322-36. doi: 10.1200/JCO.2012.45.6954. Epub 2013 May 20.

35.

Multilevel predictors of colorectal cancer screening use in California.

Shariff-Marco S, Breen N, Stinchcomb DG, Klabunde CN.

Am J Manag Care. 2013;19(3):205-16.

36.

Health care provider surveys in the United States, 2000-2010: a review.

McLeod CC, Klabunde CN, Willis GB, Stark D.

Eval Health Prof. 2013 Mar;36(1):106-26. doi: 10.1177/0163278712474001. Review.

PMID:
23378504
37.

Association of polypectomy techniques, endoscopist volume, and facility type with colonoscopy complications.

Chukmaitov A, Bradley CJ, Dahman B, Siangphoe U, Warren JL, Klabunde CN.

Gastrointest Endosc. 2013 Mar;77(3):436-46. doi: 10.1016/j.gie.2012.11.012. Epub 2013 Jan 4.

38.

Physicians' beliefs about breast cancer surveillance testing are consistent with test overuse.

Han PK, Klabunde CN, Noone AM, Earle CC, Ayanian JZ, Ganz PA, Virgo KS, Potosky AL.

Med Care. 2013 Apr;51(4):315-23. doi: 10.1097/MLR.0b013e31827da908.

39.

Breast and colorectal cancer screening: U.S. primary care physicians' reports of barriers.

Meissner HI, Klabunde CN, Breen N, Zapka JM.

Am J Prev Med. 2012 Dec;43(6):584-9. doi: 10.1016/j.amepre.2012.08.016.

PMID:
23159253
40.

Improving the quality of surveys of physicians and medical groups: a research agenda.

Klabunde CN, Willis GB, McLeod CC, Dillman DA, Johnson TP, Greene SM, Brown ML.

Eval Health Prof. 2012 Dec;35(4):477-506. doi: 10.1177/0163278712458283. Epub 2012 Sep 3.

PMID:
22947596
41.

Variation in primary care physicians' colorectal cancer screening recommendations by patient age and comorbidity.

Haggstrom DA, Klabunde CN, Smith JL, Yuan G.

J Gen Intern Med. 2013 Jan;28(1):18-24. doi: 10.1007/s11606-012-2093-6. Epub 2012 Jun 1.

42.

Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey.

Doria-Rose VP, White MC, Klabunde CN, Nadel MR, Richards TB, McNeel TS, Rodriguez JL, Marcus PM.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1049-59. doi: 10.1158/1055-9965.EPI-12-0343. Epub 2012 May 9.

43.

Screening colonoscopy in the US: attitudes and practices of primary care physicians.

Zapka J, Klabunde CN, Taplin S, Yuan G, Ransohoff D, Kobrin S.

J Gen Intern Med. 2012 Sep;27(9):1150-8. doi: 10.1007/s11606-012-2051-3. Epub 2012 Apr 27.

44.

Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey.

Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A.

Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):895-904. doi: 10.1158/1055-9965.EPI-12-0192. Epub 2012 Apr 6.

45.

Lung cancer screening practices of primary care physicians: results from a national survey.

Klabunde CN, Marcus PM, Han PK, Richards TB, Vernon SW, Yuan G, Silvestri GA.

Ann Fam Med. 2012 Mar-Apr;10(2):102-10. doi: 10.1370/afm.1340.

46.

Systems strategies to support cancer screening in U.S. primary care practice.

Yabroff KR, Zapka J, Klabunde CN, Yuan G, Buckman DW, Haggstrom D, Clauser SB, Miller J, Taplin SH.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2471-9. doi: 10.1158/1055-9965.EPI-11-0783. Epub 2011 Oct 5.

47.

Physician visits and colorectal cancer testing among Medicare enrollees in North Carolina and South Carolina, 2005.

Schenck AP, Klabunde CN, Warren JL, Jackson E, Peacock S, Lapin P.

Prev Chronic Dis. 2011 Sep;8(5):A112. Epub 2011 Aug 15.

48.

Differences between primary care physicians' and oncologists' knowledge, attitudes and practices regarding the care of cancer survivors.

Potosky AL, Han PK, Rowland J, Klabunde CN, Smith T, Aziz N, Earle C, Ayanian JZ, Ganz PA, Stefanek M.

J Gen Intern Med. 2011 Dec;26(12):1403-10. doi: 10.1007/s11606-011-1808-4. Epub 2011 Jul 22.

49.

Physician over-recommendation of mammography for terminally ill women.

Leach CR, Klabunde CN, Alfano CM, Smith JL, Rowland JH.

Cancer. 2012 Jan 1;118(1):27-37. doi: 10.1002/cncr.26233. Epub 2011 Jun 16.

50.

Trends in colorectal cancer test use among vulnerable populations in the United States.

Klabunde CN, Cronin KA, Breen N, Waldron WR, Ambs AH, Nadel MR.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1611-21. doi: 10.1158/1055-9965.EPI-11-0220. Epub 2011 Jun 8.

Supplemental Content

Loading ...
Support Center